As medical researchers and clinicians, we are concerned about the proposed reductions in funding for the U.S. National ...

Objectives Small cell lung cancer (SCLC) has the most aggressive clinical course of pulmonary tumor and is treated in a different way from non-SCLC. However, the clinical value of FDG-PET/CT is not ...